Trans Genic Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY11.92 |
Market Cap |
JPY8.13 B |
Shares Outstanding |
17.37 M |
Public Float |
16.36 M |
Address |
ibb Fukuoka, 2/F Fukuoka Fukuoka 810 Japan |
Employees | - |
Website | http://www.transgenic.co.jp |
Updated | 07/08/2019 |
Trans Genic Inc. engages in the research and development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Genomics, CRO Business, Antibody and Reagent, and Pathological Diagnosis. The Genomics segment conducts contract knockout mouse production, gene analysis service, and sales of disease-model mouse. |